BRUNSWICK CORP (BC) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BC • US1170431092

86.69 USD
-0.43 (-0.49%)
At close: Feb 10, 2026
86.69 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BC. BC was compared to 31 industry peers in the Leisure Products industry. While BC is still in line with the averages on profitability rating, there are concerns on its financial health. BC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BC had positive earnings in the past year.
  • In the past year BC had a positive cash flow from operations.
  • Of the past 5 years BC 4 years were profitable.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • BC has a Return On Assets (-2.58%) which is comparable to the rest of the industry.
  • BC's Return On Equity of -8.45% is in line compared to the rest of the industry. BC outperforms 45.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.91%, BC is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BC is in line with the industry average of 7.65%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BC has a Operating Margin of 5.83%. This is in the better half of the industry: BC outperforms 70.97% of its industry peers.
  • In the last couple of years the Operating Margin of BC has declined.
  • Looking at the Gross Margin, with a value of 24.84%, BC is doing worse than 61.29% of the companies in the same industry.
  • BC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BC is destroying value.
  • BC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BC has been reduced compared to 5 years ago.
  • BC has a better debt/assets ratio than last year.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • The Debt to FCF ratio of BC is 5.30, which is a neutral value as it means it would take BC, 5.30 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BC (5.30) is better than 61.29% of its industry peers.
  • BC has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.11, BC is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z N/A
ROIC/WACC0.65
WACC9.13%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • BC has a Current ratio of 1.44. This is in the lower half of the industry: BC underperforms 70.97% of its industry peers.
  • A Quick Ratio of 0.61 indicates that BC may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, BC is doing worse than 74.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • Measured over the past years, BC shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.40% on average per year.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • Measured over the past years, BC shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.79% on average over the next years. This is a very strong growth
  • BC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y28.79%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • BC is valuated quite expensively with a Price/Earnings ratio of 26.51.
  • 64.52% of the companies in the same industry are more expensive than BC, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.03. BC is around the same levels.
  • With a Price/Forward Earnings ratio of 19.92, BC is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, BC is valued a bit cheaper than 64.52% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BC to the average of the S&P500 Index (27.97), we can say BC is valued slightly cheaper.
Industry RankSector Rank
PE 26.51
Fwd PE 19.92
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BC is cheaper than 67.74% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BC is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.23
EV/EBITDA 12.42
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • BC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BC's earnings are expected to grow with 30.21% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y27.83%
EPS Next 3Y30.21%

6

5. Dividend

5.1 Amount

  • BC has a Yearly Dividend Yield of 1.98%.
  • Compared to an average industry Dividend Yield of 1.26, BC pays a bit more dividend than its industry peers.
  • BC's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

  • On average, the dividend of BC grows each year by 11.57%, which is quite nice.
  • BC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.57%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of BC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-82.01%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

BRUNSWICK CORP

NYSE:BC (2/10/2026, 8:04:00 PM)

After market: 86.69 0 (0%)

86.69

-0.43 (-0.49%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners110.83%
Inst Owner Change-1.17%
Ins Owners0.94%
Ins Owner Change-0.93%
Market Cap5.64B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts75.71
Price Target89.89 (3.69%)
Short Float %4.57%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend1.72
Dividend Growth(5Y)11.57%
DP-82.01%
Div Incr Years12
Div Non Decr Years16
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)15.85%
PT rev (3m)19.89%
EPS NQ rev (1m)-29.35%
EPS NQ rev (3m)-30.38%
EPS NY rev (1m)1.98%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)2.6%
Revenue NY rev (3m)4.85%
Valuation
Industry RankSector Rank
PE 26.51
Fwd PE 19.92
P/S 1.05
P/FCF 14.23
P/OCF 10.03
P/B 3.47
P/tB 62.93
EV/EBITDA 12.42
EPS(TTM)3.27
EY3.77%
EPS(NY)4.35
Fwd EY5.02%
FCF(TTM)6.09
FCFY7.03%
OCF(TTM)8.64
OCFY9.97%
SpS82.45
BVpS24.99
TBVpS1.38
PEG (NY)0.8
PEG (5Y)N/A
Graham Number42.88
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 250
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z N/A
F-Score5
WACC9.13%
ROIC/WACC0.65
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y28.79%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.06%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year98.59%
EBIT Next 3Y35.47%
EBIT Next 5Y26.24%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the valuation of BRUNSWICK CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUNSWICK CORP (BC) is 26.51 and the Price/Book (PB) ratio is 3.47.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.